The glory days of Target seem to be over. Here's why pricey merchandise, a DEI misstep, and clunky "fixes" are keeping ...

Walmart has blown past Target in their long-running rivalry.

CytoMed Therapeutics Limited (NASDAQ: GDTC) (“CytoMed” or “Company”), a Singapore-based clinical stage biopharmaceutical ...

LYL273 has demonstrated a 67% overall response rate, an 83% disease control rate, and a manageable safety profile at the ...

Enara Bio Ltd. is staking a claim to having validated the first in a new class of tumor antigens derived from unannotated regions of the dark genome, describing its findings in talks and posters being ...

(Reuters) -Novo Nordisk has decided to discontinue its cell therapy research and development efforts, a spokesperson for the Danish drugmaker told Reuters on Friday. Bloomberg News first reported on ...

CAR T-cell therapy was first developed as a lymphoma treatment but has recently been applied to autoimmune diseases, primarily lupus, systemic sclerosis, and myositis. Up to this point, ulcerative ...

Dr. Christina Cho highlights the Adult Stem Cell Transplant and Cellular Therapy Program for its innovative research and compassionate, multidisciplinary team. Dr ...

Sarah Burris is a long-time veteran of political campaigns, having worked as a fundraiser and media director across the United States. She transitioned into reporting while working for Rock the Vote, ...

Hate to pay big wireless bills? Consumer Cellular has other ideas. And to make its case, it used Oklahoma State football coach Mike Gundy. In 2007, he had a famous “I’m a man, I’m 40” rant against ...

Tony Aquilio is all in favor of using technology as an educational tool. But even Aquilio, Penn-Trafford High School’s principal, admits access to personal cellphones can be bad for learning while in ...